Instem Presenting at British Society of Toxicological Pathology Annual Meeting
Instem to discuss how public and private literature can provide insight into which preclinical models best represent drug-induced pathology in humans
CONSHOHOCKEN, PA – November 12, 2014 - - Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce that Paul Bradley, Head of Life Sciences at Instem, will be presenting a poster at the British Society of Toxicological Pathology (BSTP) 29th Annual Scientific Meeting in Cheshire, UK.
The poster presentation, "What does the literature tell us about the relationship between drug-induced stomatitis in preclinical models and man?" will discuss how Instem’s suite of insight solutions can be used to search, model and visualize both publicly available literature and Instem’s in-house knowledgebase to determine which preclinical models best represent drug-induced pathology in humans.
The 29th Annual BSTP meeting is being held jointly with the Association of Comparative Clinical Pathology (ACCP) and the Minipig Research Forum (MRF). The theme of the meeting is “Rational Selection of the Non-Rodent Species: Toxicology, Pathology and Relevance to Man”. The meeting is being held at AstraZeneca’s Alderley Park site, Cheshire, UK on November 13th & 14th.
The poster will be on display in the BSTP Exhibit Hall throughout the meeting. Instem will also be exhibiting at booth # 4, where delegates will have the opportunity to try out Instem’s powerful insight solutions for themselves. Delegates are invited to bring along a specific compound or Pathology finding that they would like to know more about, and Instem’s booth team will undertake an initial no-fee literature search.
At the BSTP booth, Instem will also be showcasing its market-leading Provantis® Pathology solution for the collection, processing and reporting of data for gross and histopathology and its submit™ solution suite for creating, managing and reviewing SEND data sets.
The BSTP is a non-profit organization that seeks to advance pathology for the public benefit in all its aspects pertaining to the effects of extraneous substances and environmental agents to which man or other species are exposed through design or adventitiously. Additionally it seeks to foster training and advance education in toxicological pathology by providing continuing professional development seminars and educational training modules.
Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
Meeting clients at the intersection of investment & return™.
Gary Mitchell (US HQ)
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600